Balaxi Pharmaceuticals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Jun' 24	Mar' 24	Dec' 23	Sep' 23	Jun' 23

Sales

19.03

15.90

12.70

16.55

25.04

Operating profit

1.51

0.20

0.28

0.91

3.77

Interest

0.35

0.51

0.41

0.36

0.26

Gross profit

2.00

-0.15

0.90

1.70

3.64

EPS (Rs)

0.25

-0.11

0.10

0.23

0.50

Other income

0.85

0.16

1.03

1.15

0.13

Stock adjustment

-

-

-

-

-

Raw material

15.69

13.46

10.34

13.62

19.14

Power and fuel

-

-

-

-

-

Employee expenses

1.15

0.60

1.29

1.27

1.24

Excise

-

-

-

-

-

Admin and selling expenses

0.67

1.64

0.80

0.74

0.89

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

-

-

-

-

-

Provisions made

-

-

-

-

-

Depreciation

0.12

0.12

0.13

0.13

0.13

Taxation

0.51

0.31

0.28

0.39

0.95

Net profit / loss

1.38

-0.58

0.49

1.18

2.55

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

11.04

10.90

10.23

10.23

10.23

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

7.94

1.25

2.20

5.52

15.06

GPM (%)

10.08

-.92

6.54

9.62

14.46

NPM (%)

6.93

-3.58

3.56

6.68

10.15